Pharmacological prevention of diabetic cataract
- 1 March 2004
- journal article
- review article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 18 (2), 129-140
- https://doi.org/10.1016/s1056-8727(03)00009-6
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- Metabolic regulation of aldose reductase activity by nitric oxide donorsChemico-Biological Interactions, 2001
- Preventive Effect of Vitamin E-Containing Liposome Instillation on Cataract Progression in 12-Month-Old Rats Fed a 25% Galactose DietJournal of Ocular Pharmacology and Therapeutics, 2000
- Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapyGeneral Pharmacology: The Vascular System, 1996
- Role of site-specific, metal-catalyzed oxidation in lens aging and cataract: A hypothesisExperimental Eye Research, 1990
- The role of lens epithelium in sugar cataract formationExperimental Eye Research, 1990
- Current progress in clinical trials of aldose reductase inhibitors in JapanExperimental Eye Research, 1990
- Clinical trials with aldose reductase inhibitorsExperimental Eye Research, 1990
- A thirty year journey in the polyol pathwayExperimental Eye Research, 1990
- The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteinsExperimental Eye Research, 1990
- Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylationLife Sciences, 1988